NSC |
Compound |
Enrichment |
Correlation |
NSC 724827 |
1,4-di-N-oxide-6,7-difluoro-2-ethylcarbonyl-3-trifluoromethy lquinoxaline |
0.0339770934764516 |
0.27803244 |
NSC 725202 |
Null |
0.0339770934764516 |
0.31694468 |
NSC 727012 |
(2S,3S)-3,4-Epoxy-2-(3-methoxy-5-methyl-1-naphthoyloxy)-3-methylbutanamide |
0.0339770934764516 |
0.27804789 |
NSC 727759 |
1-benzyl-3-chloro-4-(3-chloroanilino)-2,5-dihydro-1H-2,5-pyr roledione |
0.0339770934764516 |
0.19866376 |
NSC 727985 |
NSC 708781 incorporated in micelles, 0.55% (w/w) of drug |
0.0339770934764516 |
0.26598543 |
NSC 728319 |
6-(3-Homopiperazinyl1-1-propyl)-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride |
0.0339770934764516 |
0.65490068 |
NSC 730460 |
16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate |
0.0339770934764516 |
0.39259522 |
NSC 744449 |
Null |
0.0339770934764516 |
-0.09670055 |
NSC 745957 |
2-Benzylthio-4-chloro-N-[imino(3,4,5-trimethylpyrazol-1-yl)methyl]-5-methylbenzenesulfonamide |
0.0339770934764516 |
0.1183922 |
NSC 750035 |
Null |
0.0339770934764516 |
0.32827008 |